TMO relative to IQV
Thermo Fisher Scientific Inc is the relatively depressed leg. IQVIA Holdings Inc is the relatively extended leg.
What is the play in TMO / IQV?
This is a relative trade. The result depends on which security performs better, not on whether the whole market rises or falls.
Keep TMO / IQV on routine watch
The two securities are not far enough apart, with enough confirmation, to support a useful convergence case.
This is the relatively depressed leg. The case needs it to recover or at least hold up better than the other leg.
This is the relatively extended leg. The case needs it to lag or weaken relative to the long leg.
A favourable relative move means TMO rises more than IQV, falls less than IQV, or rises while IQV falls. If IQV outperforms TMO, the pair moves against the case.
A future case would need an unusual separation, a dependable relationship and evidence favouring TMO over IQV.
There is no reason to force a long or short leg while the relationship remains near normal.
There is no active case to invalidate because no relative-value position is currently supported.
Keep the pair on the relationship map and wait for a meaningful, evidence-backed separation.
Evidence now
- TMO Market Dynamics is improving.
What would invalidate it?
There is no current dislocation edge; transaction costs can dominate small spread movements.
How the relative-value idea could be expressed
These are research structures, not recommendations or position-size instructions. The current course above determines whether any structure is ready to study now.
Long TMO / short IQV
Treat both legs as one relative position. The setup looks for TMO to outperform IQV; TMO can rise faster, fall less, or rise while IQV falls. The pair loses ground when IQV outperforms TMO.
When it becomes relevantThis is a structure to study only after the current course changes from โNo setup at presentโ to confirmed convergence. A new, unusual separation would need to develop while the historical relationship remains dependable.Principal riskRequires a live review of both legs, borrow availability and cost, event dates, liquidity and the research normalisation.Study TMO alone if its own evidence confirms
This simpler expression focuses on recovery in TMO. It avoids short-borrow mechanics, but it no longer isolates relative value: the result is exposed to the broad market, the sector and TMO-specific news.
When it becomes relevantA stronger case needs improving TMO price structure and supporting evidence, not just a wide relationship gap.Principal riskCarries full single-security and broad-market direction risk.Study IQV alone if its support continues to weaken
This expression focuses on weakness in IQV. It may fit a leader-rollover case, but it also abandons the relative hedge and adds direct market direction, squeeze and company-event risk.
When it becomes relevantWeakening in IQV must be visible in its own completed evidence; relative extension alone is not enough.Principal riskShort selling can involve unlimited loss, borrow fees, recalls and forced close-outs.Any practical expression needs an independent review of suitability, portfolio risk, liquidity, current news and earnings, borrow availability and cost, transaction costs and tax.
How far apart are they compared with normal?
Zero is the pair's historical centre. The outer guides show increasingly unusual departures from it.
This is the relationship gap after allowing for the pair's usual co-movement. Zero is its historical centre; the distance is measured in standard deviations, so different pairs can be compared on the same scale.
The latest gap is 0.53 standard deviations from normal. TMO is the relatively depressed leg and IQV is the relatively extended leg. That is unusual separation, not proof that either security is cheap or expensive.
A move toward zero means convergence. A move farther from zero means the separation is extending and raises the risk that the old relationship is changing.
Which security created the gap?
Both paths begin at 100 so their relative movement is visible without mixing different share prices.
Both securities are reset to 100 at the first date. This removes the distraction of different share prices and shows how their completed weekly price paths diverged. It is not a valuation chart.
Since the common starting point, IQV is +15.8% and TMO is +14.0%. The chart shows which price path contributed to the separation; the fitted relationship measure is more precise than the raw visual distance.
For convergence, watch for TMO to catch up, IQV to lose ground, or both. The relationship can close even if both securities rise or both fall.
Is the gap closing yet?
The daily relationship adds timing context inside the slower weekly case. It does not replace the weekly validity checks.
This applies the same relationship to completed daily bars. It is the timing layer inside the weekly case, not a separate trading signal.
Gap stable: The completed daily gap is broadly unchanged. There is no clear short-term turn yet.
A sustained move toward zero would add confirmation; continued flat action keeps the case on watch.
TMO ยท Thermo Fisher Scientific Inc
70/100 evidence score- Market Dynamics
- 1.278 ยท change 0.373
- Trend
- Positive
- Stage
- Stage 3 ยท Distribution
- Smart Money
- Cautious
- News sentiment
- Positive
- Options
- Mixed
IQV ยท IQVIA Holdings Inc
71/100 evidence score- Market Dynamics
- 1.473 ยท change 0.651
- Trend
- Positive
- Stage
- Stage 3 ยท Distribution
- Smart Money
- Cautious
- Short interest
- Neutral
- Options
- Mixed
Why this pair is on the map
How closely completed weekly returns moved together across the measurement window.
How consistent the fitted relationship remained across earlier and later parts of the sample.
An observed mean-reversion clock, not a deadline or a forecast.
How often the residual crossed its historical centre; repeated crossings matter more than a single fit.
The latest residual's location inside its own completed history.
Stored price, volume and size context only. It does not include a live short locate or cost.
1 of 1 non-overlapping historical separations resolved after the relationship was fitted on earlier data.
Median time to return near the earlier fitted centre among the held-out cases that resolved.
The largest further move recorded after a measured held-out separation, before resolution or the observation window ended.
What changed and when
Completed daily timing changed to gap stable through 2026-08-21.
Completed daily timing changed to gap stable through 2026-08-21.
Completed daily timing changed to gap narrowing through 2026-08-20.
Completed daily timing changed to gap extending through 2026-08-17.
Published as Balanced relationship after the completed 2026-08-14 observation.